Key result
Multi-omics fine-mapping identifies 532 pleiotropic signals and prioritizes 436 blood pressure candidate genes.
Answers are grounded in this paper and cite their sources.
Genome-wide association studies of blood pressure (BP) have identified >1,000 loci, but the effector genes and biological pathways at these loci are mostly unknown. Using published association summary statistics, we conducted annotation-informed fine-mapping incorporating tissue-specific chromatin segmentation and colocalization to identify causal variants and candidate effector genes for systolic BP, diastolic BP, and pulse pressure. We observed 532 distinct signals associated with ≥2 BP traits and 84 with all three. For >20% of signals, a single variant accounted for >75% posterior probability, 65 were missense variants in known (SLC39A8, ADRB2, and DBH) and previously unreported BP candidate genes (NRIP1 and MMP14). In disease-relevant tissues, we colocalized >80 and >400 distinct signals for each BP trait with cis-eQTLs and regulatory regions from promoter capture Hi-C, respectively. Integrating mouse, human disorder, gene expression and tissue abundance data, and literature review, we provide consolidated evidence for 436 BP candidate genes for future functional validation and discover several potential drug targets.
No takes yet. Share an insight, caveat, or question.
Duijvenboden et al. (2023) studied Hypertension / Blood pressure traits. Genetic fine-mapping and multi-omics integration was evaluated on Identification of causal genetic variants and candidate effector genes for systolic BP, diastolic BP, and pulse pressure. Annotation-informed fine-mapping and multi-omics integration identified 532 distinct signals associated with >=2 BP traits and consolidated evidence for 436 BP candidate genes.
Synapse has enriched 10 related papers. Consider them for comparative context: